GlassScriptPhysician profile
Britney M Smith
NPI 1043671951
$1,485.37
in general payments reported to CMS, 2019-2025
11 companies · $608 in 2025
The $608 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.20 · 2022: $596 · 2023: $73.73 · 2024: $164 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $693.25 | 2022-2025 | |
| Abbott Laboratories | $318.39 | 2023-2025 | Eterna, Proclaim |
| Collegium Pharmaceutical, INC. | $170.96 | 2025 | Belbuca |
| Stryker Corporation | $105.40 | 2024 | Spinejack |
| Pfizer INC. | $82.96 | 2021-2023 | |
| Saluda Medical Americas, INC. | $25.80 | 2025 | Evoke |
| Pacira Pharmaceuticals Incorporated | $24.87 | 2025 | Zilretta |
| Vertex Pharmaceuticals Incorporated | $17.21 | 2025 | |
| Boston Scientific Corporation | $16.25 | 2024 | Artisan |
| Janssen Pharmaceuticals, INC | $15.86 | 2021 | |
| Daiichi Sankyo INC. | $14.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britney Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.